CARDIOLOGY SOCIETY DEVELOPMENT
ActiveSummary
CARDIOLOGY SOCIETY DEVELOPMENT has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€68,954) and a net result of €138,956. Equity has been growing by about 13% per year since 2019. Its solvency ranks better than 5% of 783 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Overview
Official details
Source: KBO- Status
- Active since 17-07-2008 Normal situation
- Activity
- Specialist medical practice NACE 86220
- Establishment unit
- 2.279.202.961 1190 Forest, since 17-07-2008
- Financial year end
- 31 January
- Peppol
- Not found in the Peppol Directory
Board and ownership
- GUIMFACQ-DJUMGUE VIRGINIEDirector
- NGATCHOU-DJOMO WILLIAMDirector
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.3%
- Turnover
- €725,873
- Profit
- €138,956
- Equity
- -€68,954
- Total assets
- €275,618
- Staff
- ≈ 0.2 FTE
- estimated
- Negative equity on 31-01-2025
- 2025 accounts filed 101 days after the deadline
Score breakdownraises riskCapped at 59: negative equity1 financial year not filed after the legal deadline; last filed accounts filed 101 days late; 1 of the last 3 accounts latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.95, cash €101,600Founded in 2008Show the evidence
Checked score
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 1% of them on solvency, 55% on liquidity and 80% on profitability.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-01-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 144 days after the deadline. In the sector (NACE 86), the median for financial year 2022 was 3 days before the deadline, and 41% of those companies filed late.
Searched, nothing found (1)
Key points
Recent changes
- · Gazette deed Annee ComptableGeneral meeting of 15-11-2023
- · Gazette deed Purpose change · Amendment of the articles · Legal-form change · Resignations & appointments“L'exercice de la médecine,plus particulièrement de la médecine cardiovasculaire,ainsi que la recherche…” (deed in French)
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as CARDIOLOGY SOCIETY DEVELOPMENT: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €255,000 and €365,000, founded between 2005 and 2009.
| Company | Total assets | Gross margin |
|---|---|---|
| CARDIOLOGY SOCIETY DEVELOPMENT Forest | €275,618 | €199,192 |
| Dr BETEK Ans | €264,045 | €196,361 |
| Société Médicale du Docteur Florence RIGO Chaudfontaine | €290,804 | €200,995 |
| Dr. Dirk Vervloessem Duffel | €255,065 | €190,097 |
| DR. NICO COENEN Hasselt | €291,450 | €180,890 |
| NOSELE Woluwe-Saint-Pierre | €364,582 | €206,285 |
| MEDISCH KABINET DOKTER GODELIEVE BAETENS,PSYCHIATRIE Uccle | €336,038 | €246,078 |
Key facts about CARDIOLOGY SOCIETY DEVELOPMENT
- What is the company number of CARDIOLOGY SOCIETY DEVELOPMENT?
- The company number of CARDIOLOGY SOCIETY DEVELOPMENT is 0899.334.708. The VAT number is the same number with BE in front: BE 0899.334.708.
- Where is CARDIOLOGY SOCIETY DEVELOPMENT based?
- The registered office is at Zijdeweverijstraat 21, 1190 Forest.Company details
- What does CARDIOLOGY SOCIETY DEVELOPMENT do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of CARDIOLOGY SOCIETY DEVELOPMENT?
- CARDIOLOGY SOCIETY DEVELOPMENT is a private limited company (BV).
- When was CARDIOLOGY SOCIETY DEVELOPMENT founded?
- CARDIOLOGY SOCIETY DEVELOPMENT was founded on 17-07-2008.
- Is CARDIOLOGY SOCIETY DEVELOPMENT still active?
- Yes, CARDIOLOGY SOCIETY DEVELOPMENT is an active enterprise in the KBO register.
- What is the turnover of CARDIOLOGY SOCIETY DEVELOPMENT?
- The turnover of CARDIOLOGY SOCIETY DEVELOPMENT was €725,873 in financial year 2025, according to the filed annual accounts.Financials
- Is CARDIOLOGY SOCIETY DEVELOPMENT profitable?
- In financial year 2025, CARDIOLOGY SOCIETY DEVELOPMENT made a profit of €138,956.
- Where can I find the annual accounts of CARDIOLOGY SOCIETY DEVELOPMENT?
- CARDIOLOGY SOCIETY DEVELOPMENT filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
Next steps
See how customers, suppliers and banks see your own company and what to improve first.